These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23158609)

  • 1. Optimal initial anticoagulant therapy in pulmonary thromboembolism: randomized trial suggested.
    Koracevic GP
    Am J Emerg Med; 2013 Feb; 31(2):407-9. PubMed ID: 23158609
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of pulmonary embolism. Rivaroxaban is superior to standard therapy].
    Einecke D
    MMW Fortschr Med; 2012 Apr; 154(7):24. PubMed ID: 22558862
    [No Abstract]   [Full Text] [Related]  

  • 3. Rivaroxaban and pulmonary embolism: no better than established anticoagulant therapy.
    Prescrire Int; 2013 Dec; 22(144):290. PubMed ID: 24600727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism: EINSTEIN transforms anticoagulant therapy in acute PE.
    Kline JA; Yealy DM
    Nat Rev Cardiol; 2012 May; 9(7):378-80. PubMed ID: 22566060
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of a patient with chronic thromboembolic pulmonary hypertension with rivaroxaban.
    Ho HH; Aung TH; Wong CP; Huang W; Francis PJ; Foo D; Ong PJ; Yeo D
    Int J Cardiol; 2013 Jul; 167(2):e33-4. PubMed ID: 23590934
    [No Abstract]   [Full Text] [Related]  

  • 6. Simplifying venous thromboembolism management: a new and safer era.
    Hardy G
    Cardiovasc J Afr; 2012 Nov; 23(10):574-5. PubMed ID: 23192263
    [No Abstract]   [Full Text] [Related]  

  • 7. Rivaroxaban (Xarelto)--a new oral anticoagulant.
    Med Lett Drugs Ther; 2011 Aug; 53(1371):65-7. PubMed ID: 21860366
    [No Abstract]   [Full Text] [Related]  

  • 8. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.
    Ageno W
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):569-76. PubMed ID: 19505271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral rivaroxaban for pulmonary embolism.
    O'Donnell DM; O'Connell NM; O'Donnell JS
    N Engl J Med; 2012 Jun; 366(26):2525; author reply 2526-7. PubMed ID: 22738105
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral rivaroxaban for pulmonary embolism.
    Bhaskar E
    N Engl J Med; 2012 Jun; 366(26):2525-6; author reply 2526-7. PubMed ID: 22738106
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral rivaroxaban for pulmonary embolism.
    Claret PG; Bobbia X; de la Coussaye JE
    N Engl J Med; 2012 Jun; 366(26):2526; author reply 2526-7. PubMed ID: 22738107
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of an article: oral rivaroxaban for symptomatic venous thromboembolism. The EINSTEIN Investigators et al. N Engl J Med 2010; 363(26):2499-2510.
    Nunnelee JD
    J Vasc Nurs; 2011 Jun; 29(2):89. PubMed ID: 21558032
    [No Abstract]   [Full Text] [Related]  

  • 14. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New ESC guideline takes NOAK into account].
    Arnheim K;
    MMW Fortschr Med; 2015 Jun; 157(11):67. PubMed ID: 26049362
    [No Abstract]   [Full Text] [Related]  

  • 16. Rivaroxaban, the first oral, direct factor Xa inhibitor.
    Fassiadis N
    Expert Opin Pharmacother; 2009 Dec; 10(18):2945-6. PubMed ID: 19925048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral Rivaroxaban for the treatment of symptomatic pulmonary embolism].
    García-Bragado Dalmau F;
    Rev Clin Esp (Barc); 2013; 213(5):256-7. PubMed ID: 23940850
    [No Abstract]   [Full Text] [Related]  

  • 18. Rivaroxaban for thromboprophylaxis.
    Lotke PA
    N Engl J Med; 2008 Nov; 359(20):2174; author reply 2175-6. PubMed ID: 19009675
    [No Abstract]   [Full Text] [Related]  

  • 19. Rivaroxaban (Xarelto) for acute coronary syndrome.
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):97. PubMed ID: 22173426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is rivaroxaban noninferior to standard warfarin therapy in preventing recurrent PE and DVT?
    Graber MA; Dachs R; Endres J
    Am Fam Physician; 2013 Jun; 87(12):872-3. PubMed ID: 23939570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.